Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Schizophrenia Congress highlights Article New insights into the pathophysiology and clinical manifestations of schizophrenia Schizophrenia Article Steps towards long-term maintenance treatment for psychiatric disorders Schizophrenia Bipolar Article Cognition in schizophrenia and bipolar disorder: Potential mechanisms and possible therapies Alzheimer's Disease Article β-amyloid remains a compelling target